The Online Investor
OLI Premium
Retiree Portfolio
Stock Option Ideas
Preferred Stock List

Slideshow Secondary Stock Offerings

By The Online Investor Staff, updated Sat., Apr. 18, 3:12 AM

Slide #7. Biodel Inc. Secondary Offering

Company: Biodel Inc. (NASDAQ:BIOD)
Date announced: 4/15/2015
Shares Offered: 32,608,696
Date of Pricing: 4/15/2015
Price Per Share: $0.92
Secondary Offering Details: Biodel Inc. (NASDAQ: BIOD) today announced that it has priced a public offering of 32,608,696 shares of its common stock at a price of $0.92 per share. The offering is expected to close on April 20, 2015, subject to customary closing conditions. In addition, Biodel has granted the underwriters a 30-day option to purchase up to 4,891,304 additional shares of common stock to cover over-allotments, if any.

Biodel is a development stage company. As a biopharmaceutical company, Co. is focused on the development and commercialization of treatments for diabetes. Co.'s most advanced insulin formulation, BIOD-123, combines recombinant human insulin with its combination of excipients to increase the rate of absorption following injection. Co. is also using its excipients to develop insulin analog-based formulations using either insulin lispro or insulin aspart. Co. has two insulin analog-based formulations, BIOD-238 and BIOD-250, in clinical trial. In addition, Co. is developing room temperature glucagon presentations for use as a rescue treatment for diabetes patients experiencing hypoglycemia.
Open the BIOD Page at The Online Investor »

Company Name:  Biodel Inc
Sector:  Drugs & Pharmaceuticals
Number of ETFs Holding BIOD:  1
Total Market Value Held by ETFs:  $79788
Total Market Capitalization:  $28.00M
% of Market Cap. Held by ETFs:  0.28%

Open the BIOD Page at The Online Investor (in a new window) »

April 18, 2015    3:12 AM Eastern
Quotes delayed 20 minutes

Buy (3.33 out of 4)
62nd percentile
(ranked higher than approx. 62% of all stocks covered)
Based on Zacks ABR data;
powered by Xignite

Secondary Stock Offerings | | Copyright © 1998 - 2015, All Rights Reserved

Nothing in The Online Investor is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and stock market videos powered by Market News Video. Quote data delayed at least 20 minutes, powered by Ticker Technologies, and Mergent. Contact The Online Investor; Meet Our Editorial Staff.